These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 24965445)

  • 1. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
    Perwitasari O; Johnson S; Yan X; Howerth E; Shacham S; Landesman Y; Baloglu E; McCauley D; Tamir S; Tompkins SM; Tripp RA
    J Virol; 2014 Sep; 88(17):10228-43. PubMed ID: 24965445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication
    Jorquera PA; Mathew C; Pickens J; Williams C; Luczo JM; Tamir S; Ghildyal R; Tripp RA
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30541831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.
    Perwitasari O; Johnson S; Yan X; Register E; Crabtree J; Gabbard J; Howerth E; Shacham S; Carlson R; Tamir S; Tripp RA
    PLoS One; 2016; 11(11):e0167221. PubMed ID: 27893810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
    Pickens JA; Tripp RA
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of RAN attenuates influenza a virus replication and nucleoprotein nuclear export.
    Cao L; She Z; Zhao Y; Cheng C; Li Y; Xu T; Mao H; Zhang Y; Hui X; Lin X; Wang T; Sun X; Huang K; Zhao L; Jin M
    Emerg Microbes Infect; 2024 Dec; 13(1):2387910. PubMed ID: 39087696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes.
    Cai W; Li Y; Chen S; Wang M; Zhang A; Zhou H; Chen H; Jin M
    Antiviral Res; 2015 Jun; 118():82-92. PubMed ID: 25800824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
    Widman DG; Gornisiewicz S; Shacham S; Tamir S
    PLoS One; 2018; 13(10):e0200043. PubMed ID: 30332435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein.
    Huang F; Chen J; Zhang J; Tan L; Lu G; Luo Y; Pan T; Liang J; Li Q; Luo B; Zhang H; Lu G
    J Cell Mol Med; 2018 Mar; 22(3):1826-1839. PubMed ID: 29193684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein.
    Chang SY; Park JH; Kim YH; Kang JS; Min JY
    Biochem Biophys Res Commun; 2016 Mar; 471(2):282-9. PubMed ID: 26850850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.
    Lundberg L; Pinkham C; de la Fuente C; Brahms A; Shafagati N; Wagstaff KM; Jans DA; Tamir S; Kehn-Hall K
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005122. PubMed ID: 27902702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.
    Kashyap T; Murray J; Walker CJ; Chang H; Tamir S; Hou B; Shacham S; Kauffman MG; Tripp RA; Landesman Y
    Antiviral Res; 2021 Aug; 192():105115. PubMed ID: 34157321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export.
    Zheng W; Fan W; Zhang S; Jiao P; Shang Y; Cui L; Mahesutihan M; Li J; Wang D; Gao GF; Sun L; Liu W
    Cell Rep; 2019 May; 27(6):1875-1885.e5. PubMed ID: 31067470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.
    Jones JC; Marathe BM; Vogel P; Gasser R; Najera I; Govorkova EA
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
    Zheng Y; Gery S; Sun H; Shacham S; Kauffman M; Koeffler HP
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):487-95. PubMed ID: 25030088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins.
    Jang Y; Lee HW; Shin JS; Go YY; Kim C; Shin D; Malpani Y; Han SB; Jung YS; Kim M
    Antiviral Res; 2016 Oct; 134():77-88. PubMed ID: 27565992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner.
    Waqas FH; Shehata M; Elgaher WAM; Lacour A; Kurmasheva N; Begnini F; Kiib AE; Dahlmann J; Chen C; Pavlou A; Poulsen TB; Merkert S; Martin U; Olmer R; Olagnier D; Hirsch AKH; Pleschka S; Pessler F
    PLoS Pathog; 2023 Jul; 19(7):e1011506. PubMed ID: 37459366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
    Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
    Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleo-cytoplasmic transport as a therapeutic target of cancer.
    Gravina GL; Senapedis W; McCauley D; Baloglu E; Shacham S; Festuccia C
    J Hematol Oncol; 2014 Dec; 7():85. PubMed ID: 25476752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.